Serum Beta-enolase in Acute Myocardial Infarction

Overview

Journal Br Heart J

Specialty Cardiology & Vascular Diseases

Date 1987 Jul 1

PMID 3620239

Citations 6

Authors

M Nomura

K Kato

A Nagasaka

Y Shiga

Y Miyagi

R Fukui

H Nakano

Y Abo

S Okajima

A Nakai

Affiliations

Soon will be listed here.

Abstract

The enzyme beta-enolase (alpha beta and beta beta forms) is present in skeletal and heart muscle and catalyses the glycolysis of 2-phosphoglycerate to phosphoenolpyruvate. The enzyme was measured in serum samples from patients with acute myocardial infarction, angina pectoris, congestive heart failure, and idiopathic cardiomyopathy. Serum concentrations of beta-enolase were significantly increased in acute myocardial infarction but not in the other cardiovascular diseases. Activity peaked approximately 12 to 14 hours after an acute attack of chest pain, and then gradually decreased as the patient recovered. The rise and fall in beta-enolase concentration were faster and steeper than those of creatine kinase activity, particularly in patients in whom activities of both these enzymes were less high. The assay of beta-enolase, which is highly specific and sensitive, has considerable advantages for the early diagnosis of myocardial infarction and the diagnosis of a second episode of myocardial infarction because beta-enolase concentration increases very early and rapidly and clears quickly. These data imply that serum beta-enolase may be a more effective marker for early myocardial infarction, particularly in milder cases, than measurement of creatine kinase activity.

Citing Articles

The sodium/ascorbic acid co-transporter SVCT2 distributes in a striated membrane-enriched domain at the M-band level in slow-twitch skeletal muscle fibers.

Sandoval D, Mella J, Ojeda J, Bermedo-Garcia F, Low M, Marcellini S Biol Res. 2024; 57(1):79.

PMID: 39506870 PMC: 11542426. DOI: 10.1186/s40659-024-00554-6.

The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches.

Chen S, Zou Y, Song C, Cao K, Cai K, Wu Y Basic Res Cardiol. 2023; 118(1):48.

PMID: 37938421 PMC: 10632287. DOI: 10.1007/s00395-023-01018-w.

Extracellular vesicle distribution and localization in skeletal muscle at rest and following disuse atrophy.

Ismaeel A, Van Pelt D, Hettinger Z, Fu X, Richards C, Butterfield T Skelet Muscle. 2023; 13(1):6.

PMID: 36895061 PMC: 9999658. DOI: 10.1186/s13395-023-00315-1.

Cardiovascular biomarkers in body fluids: progress and prospects in optical sensors.

John R, Devasiya T, V R N, Adigal S, Lukose J, Kartha V Biophys Rev. 2022; 14(4):1023-1050.

PMID: 35996626 PMC: 9386656. DOI: 10.1007/s12551-022-00990-2.

Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Anderson L J Physiol. 2004; 563(Pt 1):23-60.

PMID: 15611012 PMC: 1665562. DOI: 10.1113/jphysiol.2004.080473.

References

Shaft F, BAN R, IMFELD H . Serum pyruvate kinase in acute myocardial infarction. Am J Cardiol. 1970; 26(2):143-50. DOI: 10.1016/0002-9149(70)90772-1. View

Hess B . DPN-dependent enzymes in serum. Ann N Y Acad Sci. 1958; 75(1):292-303. DOI: 10.1111/j.1749-6632.1958.tb36877.x. View

Wagner G, Roe C, Limbird L, Rosati R, Wallace A . The importance of identification of the myocardial-specific isoenzyme of creatine phosphokinase (MB form) in the diagnosis of acute myocardial infarction. Circulation. 1973; 47(2):263-9. DOI: 10.1161/01.cir.47.2.263. View

Harano Y, Adair R, VIGNOS Jr P, Miller M, Kowal J . Pyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarction. Metabolism. 1973; 22(3):493-501. DOI: 10.1016/0026-0495(73)90041-3. View

BONTE F, Parkey R, Graham K, Moore J, Stokely E . A new method for radionuclide imaging of myocardial infarcts. Radiology. 1974; 110(2):473-4. DOI: 10.1148/110.2.473. View

Bondar R, Mead D . Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem. 1974; 20(5):586-90. View

Rider C, Taylor C . Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic, immunological and kinetic properties. Biochim Biophys Acta. 1974; 365(1):285-300. DOI: 10.1016/0005-2795(74)90273-6. View

Norris R, Whitlock R, Small C . Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction. Circulation. 1975; 51(4):614-20. DOI: 10.1161/01.cir.51.4.614. View

Goldberg D, Greaves M, Fleming J, Rider C, Taylor C . Immunological determination of muscle-type enolase in the serum as a diagnostic test for myocardial infarction. Clin Chim Acta. 1975; 64(3):307-15. DOI: 10.1016/0009-8981(75)90359-9. View

10.

Herraez-Dominguez M, Goldberg D, Anderson A, Fleming J, Rider C, Taylor C . Serum enolase and pyruvate kinase activities in the diagnosis of myocardial infarction. Enzyme. 1976; 21(3):211-4. DOI: 10.1159/000458861. View

11.

Fletcher L, Rider C, Taylor C . Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase. Biochim Biophys Acta. 1976; 452(1):245-52. DOI: 10.1016/0005-2744(76)90077-2. View

12.

Catheline M, Bouget J, Aubree A, Daubert C, GOUFFAULT J, Le Gall J . [Study on myoglobinemia and its development during myocardial infarction (author's transl)]. Clin Chim Acta. 1980; 105(3):311-5. DOI: 10.1016/0009-8981(80)90110-2. View

13.

Grachev M, Matveev L, Pressman E, Roschke V . A rapid method for myoglobin radioimmunoanalysis as a diagnostic tool in myocardial infarction. Clin Chim Acta. 1982; 124(2):235-8. DOI: 10.1016/0009-8981(82)90391-6. View

14.

Kondo T, Kiriyama T, Kato Y, Kogame Y, Kaneko K, Sakurai M . [Evaluation of an infarct area using technetium-99m pyrophosphate myocardial scintigraphy]. J Cardiogr. 1982; 12(3):699-708. View

15.

Kato K, OKAGAWA Y, Suzuki F, Shimizu A, Mokuno K, Takahashi Y . Immunoassay of human muscle enolase subunit in serum: a novel marker antigen for muscle diseases. Clin Chim Acta. 1983; 131(1-2):75-85. DOI: 10.1016/0009-8981(83)90354-6. View

16.

Taylor C, Royds J, Parsons M, Timperley W . Diagnostic aspects of enolase isozymes. Isozymes Curr Top Biol Med Res. 1983; 11:95-119. View

17.

Mokuno K, Riku S, Matsuoka Y, Sobue I, Kato K . Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases. J Neurol Sci. 1984; 63(3):345-52. DOI: 10.1016/0022-510x(84)90158-8. View

18.

Nagasaka A, Nishijima K, Hidaka H, Tanaka T, Yoshida S, Nakai A . Serum cyclic 3',5'-nucleotide phosphodiesterase activity in myocardial infarction. Acta Cardiol. 1985; 40(6):613-20. View

19.

LADUE J, WROBLEWSKI F, Karmen A . Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science. 1954; 120(3117):497-9. DOI: 10.1126/science.120.3117.497. View

20.

Sobel B, Bresnahan G, Shell W, YODER R . Estimation of infarct size in man and its relation to prognosis. Circulation. 1972; 46(4):640-8. DOI: 10.1161/01.cir.46.4.640. View